Ping An Healthcare and Technology Gelecekteki Büyüme
Future kriter kontrolleri 3/6
Ping An Healthcare and Technology kazanç ve gelirin sırasıyla yıllık 53.6% ve 7% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 51.6% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 0.9% olacağı tahmin edilmektedir.
Anahtar bilgiler
53.6%
Kazanç büyüme oranı
51.6%
EPS büyüme oranı
Consumer Retailing kazanç büyümesi | 28.0% |
Gelir büyüme oranı | 7.0% |
Gelecekteki özkaynak getirisi | 0.9% |
Analist kapsamı | Good |
Son güncelleme | 15 Nov 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Nov 17Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected
Sep 27Ping An Healthcare and Technology Company Limited (HKG:1833) Shares Could Be 49% Below Their Intrinsic Value Estimate
Sep 20Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Not Quite Adding Up
Jul 17Revenues Not Telling The Story For Ping An Healthcare and Technology Company Limited (HKG:1833)
Apr 17Ping An Healthcare and Technology (HKG:1833) Is In A Strong Position To Grow Its Business
Mar 20Calculating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Jan 12Getting In Cheap On Ping An Healthcare and Technology Company Limited (HKG:1833) Is Unlikely
Dec 22We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely
Sep 27A Look At The Intrinsic Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Sep 10When Should You Buy Ping An Healthcare and Technology Company Limited (HKG:1833)?
Aug 02Here's Why We're Not Too Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Situation
Jun 26Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Could Signal Some Risk
Jun 07Is There An Opportunity With Ping An Healthcare and Technology Company Limited's (HKG:1833) 46% Undervaluation?
Apr 04Should You Think About Buying Ping An Healthcare and Technology Company Limited (HKG:1833) Now?
Feb 16We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth
Jan 23A Look At The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Jan 02Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Oct 11Estimating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Sep 14Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Jun 22We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely
Mar 01We're Not Very Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Rate
Nov 13Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?
Oct 18Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Aug 05Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?
Jul 10We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth
Apr 04If You Had Bought Ping An Healthcare and Technology (HKG:1833) Shares A Year Ago You'd Have Earned 47% Returns
Feb 28Are Institutions Heavily Invested In Ping An Healthcare and Technology Company Limited's (HKG:1833) Shares?
Jan 24We Think Ping An Healthcare and Technology (HKG:1833) Can Easily Afford To Drive Business Growth
Dec 29Does This Valuation Of Ping An Healthcare and Technology Company Limited (HKG:1833) Imply Investors Are Overpaying?
Dec 03Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 5,590 | 252 | 306 | 454 | 11 |
12/31/2025 | 5,445 | 168 | 189 | 352 | 13 |
12/31/2024 | 4,600 | 118 | 74 | 68 | 13 |
6/30/2024 | 4,545 | -21 | -387 | -351 | N/A |
3/31/2024 | 4,609 | -172 | -356 | -317 | N/A |
12/31/2023 | 4,674 | -323 | -326 | -283 | N/A |
9/30/2023 | 5,135 | -370 | -577 | -536 | N/A |
6/30/2023 | 5,596 | -418 | -829 | -789 | N/A |
3/31/2023 | 5,901 | -527 | -837 | -800 | N/A |
12/31/2022 | 6,205 | -636 | -845 | -811 | N/A |
9/30/2022 | 6,276 | -879 | -1,042 | -992 | N/A |
6/30/2022 | 6,347 | -1,121 | -1,239 | -1,174 | N/A |
3/31/2022 | 6,841 | -1,330 | -1,366 | -1,288 | N/A |
12/31/2021 | 7,334 | -1,538 | -1,492 | -1,403 | N/A |
9/30/2021 | 7,636 | -1,576 | -1,319 | -1,232 | N/A |
6/30/2021 | 7,938 | -1,614 | -1,145 | -1,060 | N/A |
3/31/2021 | 7,402 | -1,281 | -1,160 | -1,081 | N/A |
12/31/2020 | 6,866 | -948 | -1,175 | -1,102 | N/A |
9/30/2020 | 6,203 | -812 | -822 | -730 | N/A |
6/30/2020 | 5,539 | -675 | -469 | -358 | N/A |
3/31/2020 | 5,302 | -704 | -553 | -431 | N/A |
12/31/2019 | 5,065 | -734 | -637 | -504 | N/A |
9/30/2019 | 4,777 | -737 | -856 | -682 | N/A |
6/30/2019 | 4,488 | -740 | -1,075 | -859 | N/A |
3/31/2019 | 3,913 | -826 | -1,179 | -972 | N/A |
12/31/2018 | 3,338 | -912 | -1,283 | -1,085 | N/A |
9/30/2018 | 3,082 | -1,182 | -1,125 | -1,007 | N/A |
6/30/2018 | 2,542 | -990 | -866 | -827 | N/A |
3/31/2018 | 2,205 | -996 | N/A | -655 | N/A |
12/31/2017 | 1,868 | -1,002 | N/A | -484 | N/A |
9/30/2017 | 1,319 | -641 | N/A | -531 | N/A |
12/31/2016 | 601 | -758 | N/A | -263 | N/A |
12/31/2015 | 279 | -324 | N/A | -45 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 1833 önümüzdeki 3 yıl içerisinde kârlı hale gelmesi öngörülüyor; bu da tasarruf oranından ( 2.3% ) daha hızlı bir büyüme olarak değerlendiriliyor.
Kazançlar ve Piyasa: 1833 önümüzdeki 3 yıl içerisinde karlı hale gelmesi öngörülüyor ki bu da ortalama piyasa büyümesinin üzerinde kabul ediliyor.
Yüksek Büyüme Kazançları: 1833 önümüzdeki 3 yıl içinde karlı hale gelmesi bekleniyor.
Gelir ve Pazar: 1833 şirketinin gelirinin (yıllık 7% ) Hong Kong pazarından (yıllık 7.8% ) daha yavaş büyümesi öngörülüyor.
Yüksek Büyüme Geliri: 1833 şirketinin gelirinin (yıllık 7% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 1833 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 0.9 %).